248 related articles for article (PubMed ID: 27144941)
1. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
Alaee M; Danesh G; Pasdar M
PLoS One; 2016; 11(5):e0154323. PubMed ID: 27144941
[TBL] [Abstract][Full Text] [Related]
2. The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion.
Alaee M; Padda A; Mehrabani V; Churchill L; Pasdar M
Oncotarget; 2016 May; 7(18):26898-915. PubMed ID: 27058623
[TBL] [Abstract][Full Text] [Related]
3. Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin.
Parker HR; Li Z; Sheinin H; Lauzon G; Pasdar M
Cell Motil Cytoskeleton; 1998; 40(1):87-100. PubMed ID: 9605974
[TBL] [Abstract][Full Text] [Related]
4. Plakoglobin restores tumor suppressor activity of p53
Alaee M; Nool K; Pasdar M
Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
6. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
[TBL] [Abstract][Full Text] [Related]
8. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
Aktary Z; Pasdar M
PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
10. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
11. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
[TBL] [Abstract][Full Text] [Related]
12. Modification of cysteine 457 in plakoglobin modulates the proliferation and migration of colorectal cancer cells by altering binding to E-cadherin/catenins.
Kim S; Ahn SH; Yang HY; Lee JS; Choi HG; Park YK; Lee TH
Redox Rep; 2017 Nov; 22(6):272-281. PubMed ID: 27571934
[TBL] [Abstract][Full Text] [Related]
13. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
[TBL] [Abstract][Full Text] [Related]
14. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
[TBL] [Abstract][Full Text] [Related]
15. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
16. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
[TBL] [Abstract][Full Text] [Related]
17. Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression.
Yi Y; Cheng JC; Klausen C; Leung PCK
Exp Cell Res; 2019 Sep; 382(2):111471. PubMed ID: 31229504
[TBL] [Abstract][Full Text] [Related]
18. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
Li Y; Wan X; Wei Y; Liu X; Lai W; Zhang L; Jin J; Wu C; Shao Q; Shao G; Lin Q
Oncol Rep; 2016 Jun; 35(6):3586-92. PubMed ID: 27109588
[TBL] [Abstract][Full Text] [Related]
19. Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.
Wang Y; Sheng Q; Spillman MA; Behbakht K; Gu H
Oncogene; 2012 May; 31(20):2512-20. PubMed ID: 21996746
[TBL] [Abstract][Full Text] [Related]
20. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
